Advanced search
Publication Cover
OncoTargets and Therapy Volume 14, 2021 - Issue
Submit an article Journal homepage
101
Views
14
CrossRef citations to date
0
Altmetric
Original Research

miR-210-3p Promotes Lung Cancer Development and Progression by Modulating USF1 and PCGF3

Qian Chen1 Department of Respiratory Medicine, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan, People’s Republic of China;2 Department of Respiratory Medicine, First Affiliated Hospital of Northwest Minzu University, Yinchuan, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0003-3961-6489View further author information
ORCID Icon,
Hongyu Zhang3 Department of Intervention and Vascular Surgery, People’s Hospital of Ningxia Hui Autonomous, Yinchuan, People’s Republic of China;4 Department of Intervention and Vascular Surgery, First Affiliated Hospital of Northwest Minzu University, Yinchuan, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-2930-4126View further author information
ORCID Icon,
Jianyin Zhang1 Department of Respiratory Medicine, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan, People’s Republic of China;2 Department of Respiratory Medicine, First Affiliated Hospital of Northwest Minzu University, Yinchuan, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-2710-0437View further author information
ORCID Icon,
Le Shen1 Department of Respiratory Medicine, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan, People’s Republic of China;2 Department of Respiratory Medicine, First Affiliated Hospital of Northwest Minzu University, Yinchuan, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-1470-678XView further author information
ORCID Icon,
Jing Yang1 Department of Respiratory Medicine, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan, People’s Republic of China;2 Department of Respiratory Medicine, First Affiliated Hospital of Northwest Minzu University, Yinchuan, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-0624-5151View further author information
ORCID Icon,
Yan Wang1 Department of Respiratory Medicine, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan, People’s Republic of China;2 Department of Respiratory Medicine, First Affiliated Hospital of Northwest Minzu University, Yinchuan, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-4098-3019View further author information
ORCID Icon,
JinXiu Ma1 Department of Respiratory Medicine, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan, People’s Republic of China;2 Department of Respiratory Medicine, First Affiliated Hospital of Northwest Minzu University, Yinchuan, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-0871-6703View further author information
ORCID Icon &
Bing Zhuan1 Department of Respiratory Medicine, People’s Hospital of Ningxia Hui Autonomous Region, Yinchuan, People’s Republic of China;2 Department of Respiratory Medicine, First Affiliated Hospital of Northwest Minzu University, Yinchuan, People’s Republic of ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6728-0954View further author information
ORCID Icon show all
Pages 3687-3700 | Published online: 09 Jun 2021

References

  • Du X, Zhang J, Wang J, Lin X, Ding F. Role of miRNA in lung cancer-potential biomarkers and therapies. Curr Pharm Des. 2018;23(39):5997–6010. doi:10.2174/1381612823666170714150118
  • Zhang Y, Wang Y, Wang J. MicroRNA-584 inhibits cell proliferation and invasion in non-small cell lung cancer by directly targeting MTDH. Exp Ther Med. 2018;15(2):2203–2211. doi:10.3892/etm.2017.5624
  • Zhan S, Wang C, Yin F. MicroRNA-29c inhibits proliferation and promotes apoptosis in non-small cell lung cancer cells by targeting VEGFA. Mol Med Rep. 2018;17(5):6705–6710. doi:10.3892/mmr.2018.8678
  • Sun F, Li L, Yan P, et al. Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance. Nat Commun. 2019;10(1):5324. doi:10.1038/s41467-019-13331-x
  • Lu C, Xie Z, Peng Q. MiRNA-107 enhances chemosensitivity to paclitaxel by targeting antiapoptotic factor Bcl-w in non small cell lung cancer. Am J Cancer Res. 2017;7(9):1863–1873.
  • Zhang G, Zheng H, Zhang G, et al. MicroRNA-338-3p suppresses cell proliferation and induces apoptosis of non-small-cell lung cancer by targeting sphingosine kinase 2. Cancer Cell Int. 2017;17:46. doi:10.1186/s12935-017-0415-9
  • Li G, Fang J, Wang Y, Wang H, Sun CC. MiRNA-based therapeutic strategy in lung cancer. Curr Pharm Des. 2018;23(39):6011–6018. doi:10.2174/1381612823666170725141954
  • Chen Y, Min L, Ren C, et al. miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer. PLoS One. 2017;12(2):e0171751. doi:10.1371/journal.pone.0171751
  • Chen S, Shi F, Zhang W, Zhou Y, Huang J. miR-744-5p inhibits non-small cell lung cancer proliferation and invasion by directly targeting PAX2. Technol Cancer Res Treat. 2019;18:1533033819876913. doi:10.1177/1533033819876913
  • Yang X, Shi L, Yi C, Yang Y, Chang L, Song D. MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1. Am J Cancer Res. 2017;7(8):1738–1753.
  • Zhang X, Sai B, Wang F, et al. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Mol Cancer. 2019;18(1):40. doi:10.1186/s12943-019-0959-5
  • Ikeda R, Nishizawa Y, Tajitsu Y, et al. Regulation of major vault protein expression by upstream stimulating factor 1 in SW620 human colon cancer cells. Oncol Rep. 2014;31(1):197–201. doi:10.3892/or.2013.2818
  • Kim KC, Yun J, Son DJ, et al. Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1. Theranostics. 2018;8(16):4409–4428. doi:10.7150/thno.26467
  • Scelfo A, Fernández-Pérez D, Tamburri S, et al. Functional landscape of PCGF proteins reveals both RING1A/B-Dependent-and RING1A/B-independent-specific activities. Mol Cell. 2019;74(5):1037–1052.e1037. doi:10.1016/j.molcel.2019.04.002
  • Kitamura S, Tanahashi T, Aoyagi E, et al. Response predictors of S-1, cisplatin, and docetaxel combination chemotherapy for metastatic gastric cancer: microarray analysis of whole human genes. Oncology. 2017;93(2):127–135. doi:10.1159/000464329
  • Wu Y, Zhang J, Hong Y, Wang X. Effects of kanglaite injection on serum miRNA-21 in patients with advanced lung cancer. Med Sci Monit. 2018;24:2901–2906. doi:10.12659/MSM.909719
  • Liang C, Zhang X, Wang HM, et al. MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer. Cell Death Dis. 2017;8(5):e2764. doi:10.1038/cddis.2017.145
  • Świtlik W, Karbownik MS, Suwalski M, Kozak J, Szemraj J. miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: a preliminary study. Cancer Biomarkers. 2018;21(2):479–488. doi:10.3233/CBM-170767
  • Zhang L, Handel MV, Schartner JM, et al. Regulation of IL-10 expression by upstream stimulating factor (USF-1) in glioma-associated microglia. J Neuroimmunol. 2007;184(1–2):188–197. doi:10.1016/j.jneuroim.2006.12.006

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.